Across his 25 years with the 280SL, Ian has shared the cockpit with many navigators including the late Nigel Raeburn, winner ...

Conventional petrol power has joined the new-generation MG ZS hybrid launched last year. Is the more powerful turbo model the ...

Now, reports suggest that the MG S5 EV will soon replace the ZS EV in global markets. The all-electric SUV is set to launch in Europe later this year, with an India debut expected in early 2026, as ...

MG Motor India is set to ace up its line-up with the premium MG Select dealerships coming in place. The carmaker took the veils of a few new vehicles at Bharat Mobility Global Expo 2025.

Finally, MG also offers an Xpower edition with dual motors that comes with greatly increased power but a reduced 245-mile range. While it’s unclear if the new MG4 will be available under three named ...

This is the next-generation MG 4… or is it an MG 3 EV, or an MG E5? Car News China has shared these images from a Chinese Ministry of Industry and Information Technology (MIIT) filing. These filings ...

Compact cars like the MG ZS SUV and MG 3 city car were often lauded for their affordable price and value-for-money features but showed room for improvement in dynamics and technology. With an all ...

JSW MG Motor India has launched the MG Comet EV 2025. While the electric car can be bought at a starting price of Rs 7 lakh (ex-showroom), the battery-as-a-service (BaaS) model allows you to have it ...

He’s not alone in his concerns. A study published by UK-based research firm Economist Impact in November 2024 found that 68 per cent of Gen Zs in Singapore lack confidence in maintaining their ...

Toyota HiLux and Ford Ranger rival dons the blue and white checks as a police car mock-up Ripe for a refresh: 2025 Chery Omoda 5 cosmetic and packaging update timely in battle with Hyundai Kona, MG ZS ...

What is the most significant Ford of all time? The Model T from 1908 is the undeniable answer, since its unheard-of ...

Rina-S 120 mg/m2 Q3W at a median on-study follow-up of 48 weeks showed encouraging antitumor activity; the confirmed ORR was 55.6%, the disease control rate was 88.9%, and the median duration of ...